13G Filing: Great Point Partners and Catalyst Pharmaceuticals Inc. (CPRX)

Page 2 of 10 – SEC Filing

CUSIP No.   14888U101 13G Page
2 of 9 Pages
1.

NAMES OF REPORTING PERSONS

Great Point Partners, LLC

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):

37-1475292

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
3. SEC USE ONLY
   
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING PERSON

WITH

5. SOLE VOTING POWER
0
6. SHARED VOTING POWER
5,262,346
7. SOLE DISPOSITIVE POWER
0
8. SHARED DISPOSITIVE POWER
5,262,346
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,262,346
   
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  o
     
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.14%1
12. TYPE OF REPORTING PERSON (See Instructions)
IA
1 Based on a total
of 102,474,498 shares outstanding, as reported in the Issuer’s Form 424B5 Prospectus filed with the SEC on November 28, 2017 (such
share number inclusive of the underwriters’ exercise of their option to purchase additional shares in full as referenced
therein).
Follow Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX)